FarmaMondo
Switzerland · Pharma & Healthcare
LeaveRussia detail: Continue Operations
A fast growing Swiss-headquartered pharmaceutical group focused on providing market access and specialty distribution services, through a unique infrastructure and geographical footprint, targeted to facilitate patient access to medicines across the unlicensed and licensed product phases.
Business in Russia
Customs data shows that the latest deliveries were in Mar 2022.
Decision trail
Decision date 05/12/2023 · Reference ↗
Significantly increased revenue, profit and taxes paid in Russia in 2022 vs 2021. Revenue increased in 2024 vs 2023 by more than +30%.
Local stats (LeaveRussia)
Staff(RF), 2021
39
Revenue(RF), mln.USD
204
Capital(RF), mln.USD
21
Assets(RF), mln.USD
25
Taxes(RF), mln.USD
13
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional